Arcus Biosciences Inc. (RCUS)

7.72

-0.13 (-1.66%)

At close: Apr 01, 2025, 3:59 PM

7.71

-0.11%

After-hours: Apr 01, 2025, 07:50 PM EDT

Arcus Biosciences Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-283M	-307M	-267M	52.83M	-122.86M
Depreciation & Amortization	10M	8M	6M	3.84M	4.19M
Stock-Based Compensation	76M	73M	65M	55M	22M
Other Working Capital	-9M	-85M	615M	-367.88M	178.38M
Other Non-Cash Items	5M	-9M	11M	3.47M	-46K
Deferred Income Tax	n/a	n/a	n/a	4.77M	n/a
Change in Working Capital	22M	-71M	623M	-375.62M	208.06M
Operating Cash Flow	-170M	-306M	438M	-256.17M	111.17M
Capital Expenditures	-6M	-24M	-12M	-26.08M	-3.06M
Acquisitions	n/a	n/a	n/a	-22M	431M
Purchase of Investments	-1.04B	-788M	-1.24B	-718.87M	-739.66M
Sales Maturities Of Investments	965M	1.01B	837M	741.08M	308.35M
Other Investing Acitivies	n/a	n/a	3M	22M	-431M
Investing Cash Flow	-84M	194M	-413M	-3.87M	-434.37M
Debt Repayment	47M	n/a	n/a	5M	n/a
Common Stock Repurchased	n/a	n/a	n/a	-6K	-54K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2M	8M	33M	12.34M	4.67M
Financial Cash Flow	277M	33M	33M	237.34M	438.68M
Net Cash Flow	23M	-79M	58M	-22.7M	115.48M
Free Cash Flow	-176M	-330M	426M	-282.25M	108.11M